Calidi Biotherapeutics, Inc. (CLDI) Operating cash flow 2022–2025
Calidi Biotherapeutics, Inc. (CLDI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$21.3MFY2025 · since FY2022: -$13.2M → -$21.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$21.3M | -8.1% |
| FY2024 | -$19.7M | +27.0% |
| FY2023 | -$27.0M | -104.2% |
| FY2022 | -$13.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLDI financial trends
CLDI RevenueCLDI Net incomeCLDI Net marginCLDI Gross profitCLDI Gross marginCLDI Operating incomeCLDI Operating marginCLDI Free cash flowCLDI Capital expendituresCLDI Return on equityCLDI Stock buybacksCLDI Dividends paidCLDI Total assetsCLDI Total liabilitiesCLDI Shareholders’ equityCLDI overview →